These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 26387872)

  • 1. Increased serum levels of lipopolysaccharide and antiflagellin antibodies in patients with diarrhea-predominant irritable bowel syndrome.
    Dlugosz A; Nowak P; D'Amato M; Mohammadian Kermani G; Nyström J; Abdurahman S; Lindberg G
    Neurogastroenterol Motil; 2015 Dec; 27(12):1747-54. PubMed ID: 26387872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune activation in patients with irritable bowel syndrome.
    Liebregts T; Adam B; Bredack C; Röth A; Heinzel S; Lester S; Downie-Doyle S; Smith E; Drew P; Talley NJ; Holtmann G
    Gastroenterology; 2007 Mar; 132(3):913-20. PubMed ID: 17383420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to flagellin indicate reactivity to bacterial antigens in IBS patients.
    Schoepfer AM; Schaffer T; Seibold-Schmid B; Müller S; Seibold F
    Neurogastroenterol Motil; 2008 Oct; 20(10):1110-8. PubMed ID: 18694443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased humoral immunity in the jejunum of diarrhoea-predominant irritable bowel syndrome associated with clinical manifestations.
    Vicario M; González-Castro AM; Martínez C; Lobo B; Pigrau M; Guilarte M; de Torres I; Mosquera JL; Fortea M; Sevillano-Aguilera C; Salvo-Romero E; Alonso C; Rodiño-Janeiro BK; Söderholm JD; Azpiroz F; Santos J
    Gut; 2015 Sep; 64(9):1379-88. PubMed ID: 25209656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Colonic Tissue Levels of TLR2, TLR4 and Nitric Oxide in Patients with Irritable Bowel Syndrome.
    Koçak E; Akbal E; Köklü S; Ergül B; Can M
    Intern Med; 2016; 55(9):1043-8. PubMed ID: 27150852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiflagellin antibodies suggest infective participation in irritable bowel syndrome pathogenesis.
    Cremon C; Pallotti F; Bacchilega M; Stanghellini V; Corinaldesi R; Barbara G
    Expert Rev Gastroenterol Hepatol; 2008 Dec; 2(6):735-40. PubMed ID: 19090734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms.
    Cremon C; Gargano L; Morselli-Labate AM; Santini D; Cogliandro RF; De Giorgio R; Stanghellini V; Corinaldesi R; Barbara G
    Am J Gastroenterol; 2009 Feb; 104(2):392-400. PubMed ID: 19174797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal recruiting and activation profiles in peripheral blood mononuclear cells in response to pathogen-associated molecular patterns stimulation in patients with IBS.
    Rodríguez-Fandiño O; Hernández-Ruíz J; López-Vidal Y; Charúa L; Bandeh-Moghaddam H; Minzoni A; Guzmán C; Schmulson M
    Neurogastroenterol Motil; 2013 Nov; 25(11):872-e699. PubMed ID: 23937411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Anti-vinculin and Anti-cytolethal Distending Toxin B Antibodies in Subtypes of Irritable Bowel Syndrome.
    Rezaie A; Park SC; Morales W; Marsh E; Lembo A; Kim JH; Weitsman S; Chua KS; Barlow GM; Pimentel M
    Dig Dis Sci; 2017 Jun; 62(6):1480-1485. PubMed ID: 28451914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes.
    Dunlop SP; Hebden J; Campbell E; Naesdal J; Olbe L; Perkins AC; Spiller RC
    Am J Gastroenterol; 2006 Jun; 101(6):1288-94. PubMed ID: 16771951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Serum sTREM-1 as a Marker of Subclinical Inflammation in Diarrhea-Predominant Patients with Irritable Bowel Syndrome.
    Du C; Peng L; Kou G; Wang P; Lu L; Li Y
    Dig Dis Sci; 2018 May; 63(5):1182-1191. PubMed ID: 29516326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the interleukin 10 polymorphisms on interleukin 10 production and visceral hypersensitivity in Chinese patients with diarrhea-predominant irritable bowel syndrome.
    Zhu SW; Liu ZJ; Sun QH; Duan LP
    Chin Med J (Engl); 2019 Jul; 132(13):1524-1532. PubMed ID: 31205078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Food-specific serum IgG4 and IgE titers to common food antigens in irritable bowel syndrome.
    Zar S; Benson MJ; Kumar D
    Am J Gastroenterol; 2005 Jul; 100(7):1550-7. PubMed ID: 15984980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Ileal Immunoglobulin A Production and Immunoglobulin A-Coated Bacteria in Diarrhea-Predominant Irritable Bowel Syndrome.
    Liu Y; Yuan X; Li L; Lin L; Zuo X; Cong Y; Li Y
    Clin Transl Gastroenterol; 2020 Mar; 11(3):e00146. PubMed ID: 32352710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detectable serum flagellin and lipopolysaccharide and upregulated anti-flagellin and lipopolysaccharide immunoglobulins in human short bowel syndrome.
    Ziegler TR; Luo M; Estívariz CF; Moore DA; Sitaraman SV; Hao L; Bazargan N; Klapproth JM; Tian J; Galloway JR; Leader LM; Jones DP; Gewirtz AT
    Am J Physiol Regul Integr Comp Physiol; 2008 Feb; 294(2):R402-10. PubMed ID: 18003793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum zonulin is elevated in IBS and correlates with stool frequency in IBS-D.
    Singh P; Silvester J; Chen X; Xu H; Sawhney V; Rangan V; Iturrino J; Nee J; Duerksen DR; Lembo A
    United European Gastroenterol J; 2019 Jun; 7(5):709-715. PubMed ID: 31210949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Expression of Toll-Like Receptors 4, 5, and 9 in Small Bowel Mucosa from Patients with Irritable Bowel Syndrome.
    Dlugosz A; Zakikhany K; Acevedo N; D'Amato M; Lindberg G
    Biomed Res Int; 2017; 2017():9624702. PubMed ID: 28246611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of tumor necrosis factor-alpha and interleukin-10 gene polymorphisms in irritable bowel syndrome.
    van der Veek PP; van den Berg M; de Kroon YE; Verspaget HW; Masclee AA
    Am J Gastroenterol; 2005 Nov; 100(11):2510-6. PubMed ID: 16279907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The therapeutic effects of eliminating allergic foods according to food-specific IgG antibodies in irritable bowel syndrome].
    Yang CM; Li YQ
    Zhonghua Nei Ke Za Zhi; 2007 Aug; 46(8):641-3. PubMed ID: 17967233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of eliminating foods according to food-specific immunoglobulin G antibodies in irritable bowel syndrome with diarrhoea.
    Guo H; Jiang T; Wang J; Chang Y; Guo H; Zhang W
    J Int Med Res; 2012; 40(1):204-10. PubMed ID: 22429360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.